356 related articles for article (PubMed ID: 25997003)
1. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.
Nural-Guvener H; Zakharova L; Feehery L; Sljukic S; Gaballa M
Int J Mol Sci; 2015 May; 16(5):11482-99. PubMed ID: 25997003
[TBL] [Abstract][Full Text] [Related]
2. HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation.
Nural-Guvener HF; Zakharova L; Nimlos J; Popovic S; Mastroeni D; Gaballa MA
Fibrogenesis Tissue Repair; 2014; 7():10. PubMed ID: 25024745
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of Epigenetically Modified Adult Cardiac c-Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model.
Zakharova L; Nural-Guvener H; Feehery L; Popovic-Sljukic S; Gaballa MA
Stem Cells Transl Med; 2015 Sep; 4(9):1086-96. PubMed ID: 26240433
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation.
Somanna NK; Valente AJ; Krenz M; McDonald KS; Higashi Y; Noda M; Chandrasekar B
Hypertens Res; 2016 Oct; 39(10):709-716. PubMed ID: 27278287
[TBL] [Abstract][Full Text] [Related]
5. HDAC inhibition: A novel therapeutic approach for attenuating heart failure by suppressing cardiac remodeling.
Wang J; Hu X; Jiang H
Int J Cardiol; 2016 Jul; 214():41-2. PubMed ID: 27057972
[No Abstract] [Full Text] [Related]
6. MMP9 inhibition increases autophagic flux in chronic heart failure.
Nandi SS; Katsurada K; Sharma NM; Anderson DR; Mahata SK; Patel KP
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1414-H1437. PubMed ID: 33064567
[TBL] [Abstract][Full Text] [Related]
7. HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
Renaud L; Harris LG; Mani SK; Kasiganesan H; Chou JC; Baicu CF; Van Laer A; Akerman AW; Stroud RE; Jones JA; Zile MR; Menick DR
Circ Heart Fail; 2015 Nov; 8(6):1094-104. PubMed ID: 26371176
[TBL] [Abstract][Full Text] [Related]
8. Mocetinostat suppresses epidural fibrosis following laminectomy by inhibiting myofibroblast activation and increasing apoptosis.
Wu WJ; Wang J; Liang J; Zhou Q; Liang Y
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4467-4475. PubMed ID: 32373984
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
10. The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.
Briere D; Sudhakar N; Woods DM; Hallin J; Engstrom LD; Aranda R; Chiang H; Sodré AL; Olson P; Weber JS; Christensen JG
Cancer Immunol Immunother; 2018 Mar; 67(3):381-392. PubMed ID: 29124315
[TBL] [Abstract][Full Text] [Related]
11. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
12. Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs.
Ahmed MS; von Lueder TG; Øie E; Kjekshus H; Attramadal H
Acta Physiol Scand; 2005 May; 184(1):27-36. PubMed ID: 15847641
[TBL] [Abstract][Full Text] [Related]
13. Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure.
Lkhagva B; Lin YK; Kao YH; Chazo TF; Chung CC; Chen SA; Chen YJ
Pharmacology; 2015; 96(3-4):184-91. PubMed ID: 26304494
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.
Maki T; Nasa Y; Tanonaka K; Takahashi M; Takeo S
J Pharmacol Exp Ther; 2003 Apr; 305(1):97-105. PubMed ID: 12649357
[TBL] [Abstract][Full Text] [Related]
15. Luhong formula inhibits myocardial fibrosis in a paracrine manner by activating the gp130/JAK2/STAT3 pathway in cardiomyocytes.
Qu H; Wang Y; Wang Y; Yang T; Feng Z; Qu Y; Zhou H
J Ethnopharmacol; 2017 Apr; 202():28-37. PubMed ID: 28115285
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NADPH oxidase 4-related signaling by sodium hydrosulfide attenuates myocardial fibrotic response.
Pan LL; Liu XH; Shen YQ; Wang NZ; Xu J; Wu D; Xiong QH; Deng HY; Huang GY; Zhu YZ
Int J Cardiol; 2013 Oct; 168(4):3770-8. PubMed ID: 23830348
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.
Zhang L; Qin X; Zhao Y; Fast L; Zhuang S; Liu P; Cheng G; Zhao TC
J Pharmacol Exp Ther; 2012 Apr; 341(1):285-93. PubMed ID: 22271820
[TBL] [Abstract][Full Text] [Related]
19. Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure.
Luo J; Gao X; Peng L; Sun H; Dai G
Eur J Pharmacol; 2011 Sep; 667(1-3):314-21. PubMed ID: 21703256
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
Aune SE; Herr DJ; Mani SK; Menick DR
J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
